Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Inotiv Inc NOTV

Healthcare Biotechnology
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices... see more

Recent & Breaking News (NDAQ:NOTV)

Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021

GlobeNewswire December 13, 2021

Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research

GlobeNewswire December 13, 2021

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021

GlobeNewswire December 7, 2021

Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021

GlobeNewswire November 29, 2021

Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility

GlobeNewswire November 10, 2021

Inotiv, Inc. Completes Purchase of Envigo

GlobeNewswire November 5, 2021

Inotiv, Inc. Shareholders Approve Acquisition of Envigo

GlobeNewswire November 4, 2021

Inotiv, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire November 2, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, GSKY, GWB, VLY, NOTV; Shareholders are Encouraged to Contact the Firm

PR Newswire October 7, 2021

Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.

GlobeNewswire October 4, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ECHO, GSKY, GWB, NOTV; Shareholders are Encouraged to Contact the Firm

PR Newswire October 1, 2021

Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes

GlobeNewswire September 27, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Inotiv, Inc. - NOTV

PR Newswire September 27, 2021

ALERT: Halper Sadeh LLP Investigates DSPG, ECHO, DVCR, FIBK, NOTV, LMRK; Shareholders are Encouraged to Contact the Firm

PR Newswire September 26, 2021

Inotiv Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Inotiv, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - NOTV

Business Wire September 23, 2021

Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering

GlobeNewswire September 22, 2021

Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering

GlobeNewswire September 21, 2021

Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions

GlobeNewswire September 21, 2021

Inotiv, Inc. to Participate in the 2021 Colliers Institutional Investor Conference

GlobeNewswire August 31, 2021

BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology

Accesswire September 6, 2017